Company Announcement New Sites Commence Recruitment For Phase III Clinical Trial May 20, 2025May 21, 2025
Company Announcement Avecho receives US$3M upfront payment from Sandoz AG March 28, 2025March 28, 2025
Company Announcement Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia March 3, 2025March 3, 2025
Company Announcement Avecho’s Phase III Clinical Trial for Insomnia Commences March 26, 2024March 26, 2024
Company Announcement Avecho completes meeting with TGA confirming pathway for Phase III Clinical Trial March 14, 2024March 14, 2024
